Asceneuron gains $100m for neurodegenerative therapeutics
Clinical-stage biotech company Asceneuron has announced an oversubscribed Series C financing round, securing $100m for advancing therapeutics in neurodegenerative diseases.…
Clinical-stage biotech company Asceneuron has announced an oversubscribed Series C financing round, securing $100m for advancing therapeutics in neurodegenerative diseases.…
The US Food and Drug Administration (FDA) has granted fast track designation to Sumitomo Pharma America’s (SMPA) DSP-5336 for the…
AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases. The deal between…
Nona Biosciences has partnered with biotechnology company Alaya.bio to advance CAR-T cell therapies. The partnership will combine Nona's HCAb Harbour…
The US Food and Drug Administration (FDA) has granted fast track designation to biopharmaceutical company Mabwell’s antibody-drug conjugate (ADC) 9MW2821…
AstraZeneca has obtained Health Canada’s Notice of Compliance (NOC) for Tagrisso (osimertinib) along with pemetrexed and platinum-based chemotherapy, to treat…
Swedish research-based biopharma company BioArctic has announced that its partner Eisai has received approval from Hong Kong's Department of Health…
Rgenta Therapeutics has secured approval for its investigational new drug (IND) application for RGT-61159, an oral small molecule RNA modulator,…
PharmassêtX has received US Food and Drug Administration’s (FDA) orphan drug designation (ODD) for epigallocatechin gallate (EGCG), to treat pouchitis,…
Evotec and Pfizer have entered a multi-year partnership that will focus initially on early discovery research. As part of the…